Literature DB >> 3036205

NMR studies of the AMP-binding site and mechanism of adenylate kinase.

D C Fry, S A Kuby, A S Mildvan.   

Abstract

NMR has previously been used to determine the conformation of enzyme-bound MgATP and to locate the MgATP-binding site on adenylate kinase [Fry, D. C., Kuby, S. A., & Mildvan, A. S. (1985) Biochemistry 24, 4680-4694]. To determine the conformation and location of the other substrate, AMP, distances have been measured from Cr3+AMPPCP, a linear competitive inhibitor with respect to MgATP, to six protons and to the phosphorus atom of AMP on adenylate kinase, with the paramagnetic probe-T1 method. Time-dependent nuclear Overhauser effects (NOEs) have been used to measure five interproton distances on enzyme-bound AMP. These distances were used to determine the conformation of bound AMP in addition to its position with respect to metal-ATP. Enzyme-bound AMP exhibits a high anti-glycosyl torsional angle (chi = 110 +/- 10 degrees), a 3'-endo,2'-exo ribose pucker (delta = 105 +/- 10 degrees), and gauche-trans orientations about the C4'-C5' bond (gamma = 180 +/- 10 degrees) and the C5'-O5' bond (beta = 170 +/- 20 degrees). The distance from Cr3+ to the phosphorus of AMP is 5.9 +/- 0.3 A, indicating a reaction coordinate distance of approximately 3 A, which is consistent with an associative SN2 mechanism for the phosphoryl transfer. Ten intermolecular NOEs, from protons of the enzyme to those of AMP, were detected, indicating the proximity of at least three hydrophobic amino acids to bound AMP. These constraints, together with the conformation of AMP and the intersubstrate distances, were used to position AMP into the X-ray structure of adenylate kinase. The AMP binding site is found to be near (less than or equal to 4 A from) Leu-116, Arg-171, Val-173, Val-182, and Leu-190; all of these residues have been found to be invariant in muscle-type rabbit, calf, human, porcine [Kuby, S. A., Palmieri, R. H., Frischat, A., Fischer, A. H., Wu, L. H., Maland, L., & Manship, M. (1984) Biochemistry 23, 2393-2399], and chicken adenylate kinase [Kishi, F., Maruyama, M., Tanizawa, Y., & Nakazawa, A. (1986) J. Biol. Chem. 261, 2942-2945].

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3036205     DOI: 10.1021/bi00380a024

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  OppA, the substrate-binding subunit of the oligopeptide permease, is the major Ecto-ATPase of Mycoplasma hominis.

Authors:  Miriam Hopfe; Birgit Henrich
Journal:  J Bacteriol       Date:  2004-02       Impact factor: 3.490

2.  Adenylate kinase complements nucleoside diphosphate kinase deficiency in nucleotide metabolism.

Authors:  Q Lu; M Inouye
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  Studies on adenosine triphosphate transphosphorylases. XVIII. Synthesis and preparation of peptides and peptide fragments of rabbit muscle ATP-AMP transphosphorylase (adenylate kinase) and their nucleotide-binding properties.

Authors:  S A Kuby; M Hamada; M S Johnson; G A Russell; M Manship; R H Palmieri; G Fleming; D S Bredt; A S Mildvan
Journal:  J Protein Chem       Date:  1989-08

Review 4.  A model for the catalytic site of F1-ATPase based on analogies to nucleotide-binding domains of known structure.

Authors:  T M Duncan; R L Cross
Journal:  J Bioenerg Biomembr       Date:  1992-10       Impact factor: 2.945

5.  Refolding of urea-denatured adenylate kinase.

Authors:  H j Zhang; X R Sheng; X M Pan; J M Zhou
Journal:  Biochem J       Date:  1998-07-15       Impact factor: 3.857

6.  Agrobacterium tumefaciens VirB11 protein requires a consensus nucleotide-binding site for function in virulence.

Authors:  K M Stephens; C Roush; E Nester
Journal:  J Bacteriol       Date:  1995-01       Impact factor: 3.490

7.  Demonstration of phosphoryl group transfer indicates that the ATP-binding cassette (ABC) transporter cystic fibrosis transmembrane conductance regulator (CFTR) exhibits adenylate kinase activity.

Authors:  Christoph O Randak; Amanda R Ver Heul; Michael J Welsh
Journal:  J Biol Chem       Date:  2012-09-04       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.